Gene · 57761
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| tRNA-derived fragment tRF-30 propels diabetes-induced retinal microvascular complications by regulating STAT3 signaling. | Cell Biol Int | 2024 | 39001618 | PubTator, text mining | PubMed |
| Dynamic Cooperative Communications with Mutual Information Accumulation for Mobile Robots in Industrial Internet of Things. | Sensors (Basel) | 2024 | 39001143 | PubTator, text mining | PubMed |
| Exploring chaos and bifurcation in a discrete prey-predator based on coupled logistic map. | Sci Rep | 2024 | 38997275 | PubTator, text mining | PubMed |
| Kinetic Proofreading Can Enhance Specificity in a Nonenzymatic DNA Strand Displacement Network. | J Am Chem Soc | 2024 | 38951503 | PubTator, text mining | PubMed |
| Diverse functions of Tribbles homolog 3 in cancers and its potential as a therapeutic target. | Carcinogenesis | 2024 | 38902892 | PubTator, text mining | PubMed |
| Sink or Swim? Sleep Patterns in Highly Trained Adolescent Swimmers during the In-Season Phase of Training. | Sleep Sci | 2024 | 38846587 | PubTator, text mining | PubMed |
| Analysis of Toxic Effects of Fluoride on Ovine Follicular Granulosa Cells Using RNA-Seq. | Antioxidants (Basel) | 2024 | 38790611 | PubTator, text mining | PubMed |
| Development of TRIB3-Based Therapy as a Gene-Independent Approach to Treat Retinal Degenerative Disorders. | Int J Mol Sci | 2024 | 38731938 | PubTator, text mining | PubMed |
| Downregulation of TRIB3 enhances the sensitivity of lung cancer cells to amino acid deprivation by suppressing AKT activation. | Am J Cancer Res | 2024 | 38726284 | PubTator, text mining | PubMed |
| Supramolecular Nanofibers Ameliorate Bleomycin-Induced Pulmonary Fibrosis by Restoring Autophagy. | Adv Sci (Weinh) | 2024 | 38725147 | PubTator, text mining | PubMed |
| TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis. | Arch Oral Biol | 2024 | 38696945 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals the Wnt/Ca2+ signaling pathway with inflammation, apoptosis in nucleus pulposus degeneration. | BMC Musculoskelet Disord | 2024 | 38654287 | PubTator, text mining | PubMed |
| TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma. | Exp Hematol Oncol | 2024 | 38581035 | PubTator, text mining | PubMed |
| Retraction: TRB3 Is Involved in Free Fatty Acid-Induced INS-1-Derived Cell Apoptosis via the Protein Kinase C δ Pathway. | PLoS One | 2024 | 38568887 | PubTator, text mining | PubMed |
| The TELOMERE REPEAT BINDING proteins TRB4 and TRB5 function as transcriptional activators of PRC2-controlled genes to regulate plant development. | Plant Commun | 2024 | 38566416 | PubTator, text mining | PubMed |
| TRIB3 promotes the progression of renal cell carcinoma by upregulating the lipid droplet-associated protein PLIN2. | Cell Death Dis | 2024 | 38561354 | PubTator, text mining | PubMed |
| A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer. | Phytomedicine | 2024 | 38503154 | PubTator, text mining | PubMed |
| Decoding human in vitro terminal erythropoiesis originating from umbilical cord blood mononuclear cells and pluripotent stem cells. | Cell Prolif | 2024 | 38499435 | PubTator, text mining | PubMed |
| Regulatory RNAs in immunosenescence. | Immun Inflamm Dis | 2024 | 38456619 | PubTator, text mining | PubMed |
| Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma. | Cell Biol Int | 2024 | 38440906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57761/papers?page=8